Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011–2014)

X Li, L Zhang, Y Tian, Y Song, P Zhan… - Expert opinion on …, 2014 - Taylor & Francis
Introduction: There is a continuous need for next-generation non-nucleoside RT inhibitors
(NNRTIs) with different resistance profiles, improved safety, excellent tolerability, and …

Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011-2014).

X Li, L Zhang, Y Tian, Y Song, P Zhan… - Expert Opinion on …, 2014 - europepmc.org
In this review we intend to narrate a general and cutting-edge overview of current state of
NNRTI patents during the 2011-2014 (June) period and future perspectives. Particular focus …

[引用][C] Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011–2014)

X Li, L Zhang, Y Tian, Y Song, P Zhan… - Expert Opinion on …, 2014 - cir.nii.ac.jp
Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011 – 2014) |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …

Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011-2014)

X Li, L Zhang, Y Tian, P Zhan… - Expert opinion on …, 2014 - pubmed.ncbi.nlm.nih.gov
Introduction There is a continuous need for next-generation non-nucleoside RT inhibitors
(NNRTIs) with different resistance profiles, improved safety, excellent tolerability, and …